Conference Description
The Cancer Genetics and Epigenetics GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
The 2025 Cancer Genetics and Epigenetics GRC will showcase and delve into a spectrum of leading-edge topics integral to cancer genetics and epigenetics, inclusive of emerging (epi)-genomics engineering technologies; advancements in cancer epitranscriptomics, spatial epigenomics & tumor microenvironment epigenomic dependencies; breakthroughs in translational cancer epigenetic therapy; latest developments in genetics & epigenetics informed cancer drivers; forefront discoveries in epigenomic plasticity & tumor evolution. As these diverse topics take center stage, the conference promises to provide a comprehensive perspective on cancer genetics and epigenetics to inspire the next wave of innovations. Beyond the stimulating talks of invited speakers, there will be additional talks selected from the submitted abstracts as well as one-minute “poster preview” talks. Furthermore, the conference will incorporate designated time for interactive poster presentation sessions, mentorship and social events providing ample opportunities for scientists from across all career stages to network and mingle. This intentional design aims to foster an inclusive community-building environment, drawing interest from a broad spectrum of researchers, and to serve as a nexus for global collaboration and knowledge exchange.
The topics, speakers, and discussion leaders for the conference sessions are displayed below. The conference chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by January 18, 2025. Please check back for updates.
Keynote Session: Genetics and Epigenetics Drivers of Tumor Evolution
Discussion Leaders
-
Peter Scacheri (Amgen, United States)
Speakers
-
Mark Dawson (Peter MacCallum Cancer Centre/University of Melbourne, Australia)
-
Serena Nik-Zainal (University of Cambridge, United Kingdom)
-
Ting Wang (Washington University School of Medicine, United States)
Epigenetics of Tumor Microenvironment
Discussion Leaders
-
Genevieve Deblois (Universite de Montreal, Canada)
Speakers
-
Paola Scaffidi (European Institute of Oncology, Italy)
-
Housheng He (Princess Margaret Cancer Center, University of Toronto, Canada)
-
Direna Alonso Curbelo (Institute for Research in Biomedicine, IRB Barcelona, Spain)
-
Luca Magnani (Institute of Cancer Research, United Kingdom)
Epigenetic Therapy
Discussion Leaders
-
Federico Gaiti (Princess Margaret Cancer Centre (University Health Network), Canada)
Speakers
-
Stephen Baylin (Johns Hopkins University, United States)
-
Cheryl Arrowsmith (Princess Margaret Cancer Center, University of Toronto, Canada)
-
Ho Man Chan (AstraZeneca, United States)
-
Peter Jones (Van Andel Institute, United States)
Tumor Genetic and Epigenetic Reprogramming
Discussion Leaders
-
Giovanni Ciriello (University of Lausanne, Switzerland)
Speakers
-
David Quigley (University of California San Francisco, United States)
-
Eneda Toska (Johns Hopkins University School of Medicine, United States)
-
Andrea Sottoriva (Human Technopole, Italy)
-
Karuna Ganesh (Memorial Sloan Kettering Cancer Center, United States)
Spatial Cancer Genomics and Epigenomics
Discussion Leaders
-
Marco Gallo (Baylor College of Medicine, United States)
Speakers
-
Zuzana Tothova (Dana-Farber Cancer Institute, United States)
-
Bing Ren (University of California San Diego, United States)
-
Elisa Oricchio (ISREC-EPFL, Switzerland)
-
Rong Fan (Yale University, United States)
Epigenetic Plasticity and Heterogeneity in Cancer
Discussion Leaders
-
Katherine Chiappinelli (George Washington University, United States)
Speakers
-
Efrat Shema (Weizmann Institute of Science, Israel)
-
Celine Vallot (Institut Curie, France)
-
Johannes Zuber (IMP, Austria)
-
Yael David (Memorial Sloan Kettering Cancer Center, United States)
Genetics and Epigenetics of Non-Coding Cancer Drivers
Discussion Leaders
-
Christopher Oakes (The Ohio State University - Comprehensive Cancer Center, United States)
Speakers
-
Ozgen Deniz (Queen Mary University of London, United Kingdom)
-
Myles Brown (Dana-Farber Cancer Institute, United States)
-
Parinaz Mehdipour (University of Oxford, Ludwig institute for Cancer Research, , United Kingdom)
-
Wilbert Zwart (Netherlands Cancer Institute, The Netherlands)
Tumor Epitranscriptomics
Discussion Leaders
-
Sandra Blanco (Cancer Research Centre (CSIC - USAL), Spain)
Speakers
-
Leonie Young (Royal College of Surgeons, Ireland)
-
Chuan He (University of Chicago, United States)
-
Michaela Frye (German Cancer Research Center, Germany)
Genomics and Epigenomics Technologies
Discussion Leaders
-
Faiyaz Notta (Princess Margaret Cancer Centre, Canada)
Speakers
-
Anna Obenauf (IMP, Austria)
-
Rickard Sandberg (Karolinska Institute, Sweden)
-
Christopher Vakoc (Cold Spring Harbor Laboratory, United States)
The GRC Power Hour™
Organizers
-
Genevieve Deblois (Universite de Montreal, Canada)
-
Direna Alonso Curbelo (Institute for Research in Biomedicine, IRB Barcelona, Spain)
-
Katherine Chiappinelli (George Washington University, United States)
